Tech-TYA: eHealth Platform to Deliver Group Intervention for YA Cancer Survivors
Adapting and Testing an eHealth Platform to Deliver a Group Intervention for Young Adult Cancer Survivors
1 other identifier
interventional
7
1 country
1
Brief Summary
The purpose of this study is to adapt a web-based platform to deliver a group intervention for young adult cancer survivors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable cancer
Started Jun 2022
Shorter than P25 for not_applicable cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 9, 2022
CompletedFirst Submitted
Initial submission to the registry
September 21, 2022
CompletedFirst Posted
Study publicly available on registry
October 28, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 25, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 25, 2023
CompletedAugust 19, 2024
August 1, 2024
11 months
September 21, 2022
August 15, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Satisfaction with the eHealth intervention delivery
Immediately after the intervention and each week participants will report their satisfaction with the full program through a brief survey.
At the end of the 10-week intervention, overall and weekly satisfaction scores will be compiled
Acceptability of the eHealth intervention delivery
Immediately after the intervention participants will report their satisfaction with the full program through a brief survey.
At the end of the 10-week intervention
Acceptability of the eHealth intervention delivery
The number of sessions attended, out of a maximum of 10, will be recorded
At the end of the 10-week intervention, the number of sessions attended will be recorded
Secondary Outcomes (12)
Change in health-related quality of life (HRQOL) from baseline to immediately after the intervention
Baseline and immediately after the intervention
Change in anxiety symptoms from baseline to immediately after the intervention
Baseline and immediately after the intervention
Change in perceived cognitive function from baseline to immediately after the intervention
Baseline and immediately after the intervention
Change in depression symptoms from baseline to immediately after the intervention
Baseline and immediately after the intervention
Change in perceived emotional support from baseline to immediately after the intervention
Baseline and immediately after the intervention
- +7 more secondary outcomes
Study Arms (1)
Behavioral: Cognitive-Behavioral Stress Management and Health Education
EXPERIMENTALWeekly video conference groups led by a trained facilitator
Interventions
Participants will attend group sessions with a trained facilitator held over videoconference. Sessions will each last 2 hours and be held once weekly for 10 weeks. Sessions will include Cognitive-Behavioral Stress Management and health education content.
Eligibility Criteria
You may qualify if:
- Aged 18-39 years at the time of participation
- Diagnosed with a primary cancer between 18-39 years old
- Finished cancer treatment with curative intent 1 month to 5 years prior to enrollment (except hormone therapy)
- NED and no anticipated/scheduled anti-cancer treatments at the time of enrollment (except hormone therapy)
- Able to speak and read English
- Able and willing to give informed consent
- Access to internet or cellular connectivity with sufficient bandwidth to participate in videoconferences (Part 2 only)
You may not qualify if:
- Ongoing or future anti-cancer treatments (beyond hormone therapy) are scheduled or anticipated
- Documented or observable psychiatric or neurological disorders that could interfere with study participation (e.g., psychosis, active substance abuse)
- Vulnerable populations will not be included in this study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Arizona Cancer Center
Tucson, Arizona, 85724, United States
Related Publications (2)
Fox RS, Badger TA, Moya S, Gudenkauf LM, Nelson MA, O'Neill RM, Leete JJ, Friedman SE, Katsanis E, Victorson DE, Sanford SD, Penedo FJ, Antoni MH, Oswald LB. An HRQOL Proof-Of-Concept Analysis of the eHealth TOGETHER Intervention for Adolescent and Young Adult Cancer Survivors: A Brief Report. Psychooncology. 2025 Jul;34(7):e70234. doi: 10.1002/pon.70234.
PMID: 40879639DERIVEDFox RS, Torres TK, Badger TA, Katsanis E, Yang D, Sanford SD, Victorson DE, Yanez B, Penedo FJ, Antoni MH, Oswald LB. Delivering a Group-Based Quality of Life Intervention to Young Adult Cancer Survivors via a Web Platform: Feasibility Trial. JMIR Cancer. 2024 Dec 4;10:e58014. doi: 10.2196/58014.
PMID: 39631050DERIVED
MeSH Terms
Conditions
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 21, 2022
First Posted
October 28, 2022
Study Start
June 9, 2022
Primary Completion
April 25, 2023
Study Completion
April 25, 2023
Last Updated
August 19, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share